Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com’s Dividend Insider Elite. Sign-up for a FREE trial here.
EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices to treat obesity, metabolic diseases and other gastrointestinal disorders, and AMITA Health, a health system focused on delivering the most efficient, highest quality, faith-based care, today announced that AMITA Health Adventist Medical Center Bolingbrook in Bolingbrook, Illinois successfully completed its first implant of the Company’s vBloc® Neurometabolic Therapy. The procedure was performed approximately three months ago by Vafa Shayani, M.D., a bariatric surgeon at the AMITA Health Bariatric & Weight Loss Center, and the patient already has lost about 30 pounds.
“vBloc Therapy is an anatomy-preserving and minimally invasive option where we do not cut or alter any part of the stomach or digestive tract,” said Dr. Shayani. “For many patients, there are few effective options outside of drastic anatomy-altering surgeries to help them successfully manage their weight and commonly associated conditions such as diabetes, high blood pressure and high cholesterol. AMITA Health is excited to now offer this revolutionary weight-loss procedure to our patients.”
The vBloc System works to control sensations of hunger using a pacemaker-like device that is implanted under the skin during a safe, minimally invasive procedure that does not alter or remove any patient anatomy. The device can be adjusted to optimize patients’ therapy needs and works to give the patient a sensation of fullness, empowering them to eat less, control their appetite, and lose weight. Studies have shown that vBloc Therapy produces meaningful weight loss in patients as well as meaningful improvements in related comorbidity factors, such as hemoglobin A1c (HbA1c), without the major lifestyle implications of traditional weight-loss surgeries.
“With the obesity…